Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma
Melanoma is the deadliest type of skin cancer with steadily increasing incidence worldwide during the last few decades.In addition to its tumor associated hdw1620dnpk antigens (TAAs), melanoma has a high mutation rate compared to other tumors, which promotes the appearance of tumor specific antigens (TSAs) as well as increased lymphocytic infiltrat